| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |